LDN2009: Conference

Monday, October 19, 2009

Lister Hill Auditorium in the National Library of Science Building

National Institutes of Health

Bethesda, Maryland

8:30 a.m.	Registration and Continental Breakfast
9:45 a.m.	Opening Remarks – Sunny O’Malley
10:00 a.m.	Keynote Speaker – Dr. Burt Berkson. Las Cruces, NM
12:00 p.m.	Lunch
1:00 p.m.	A Pharmacist’s Perspective – Dr. Skip Lenz
2:00 p.m.	Break
2:15 p.m.	The author of Up A Creek With A Paddle, Mary Boyle Bradley
3:30 p.m.	Conference Adjourns
3:35 – 5:00 p.m.	Conference attendees are invited to join us immediately following the conference for a light reception in the reception area located at the entrance of the National Library of Medicine.

"Low Dose Naltrexone (LDN) may well be the most important therapeutic breakthrough in over fifty years. It provides a new, safe and inexpensive method of medical treatment by mobilizing the natural defenses of one's own immune system.

LDN substantially reduces health care costs and improves treatment of a wide array of diseases. Unfortunately, because naltrexone has been without patent protection for many years, no pharmaceutical company will bear the expense of the large clinical trials necessary for FDA approval of LDN’s new special uses. It is now up to public institutions to seize the opportunity that LDN offers."

David Gluck, MD